Back to Market返回行情

CTKB Cytek Biosciences, Inc.

USHealthcare
$4.62+0.65%ClosedMarket Cap: $596.6M

As of 2026-07-10 16:00

Why CTKB matters now

Cytek Biosciences, Inc. (CTKB) is a US stock in Healthcare. The latest InvestLog snapshot shows $4.62 with +0.65% on the session and $596.6M in market capitalization; recent performance reads 1-month +5.60% and YTD -25.35%.

The latest financial table shown here is Q1 2026, with revenue of $44.1M, net income of $-18.9M, and EPS of $-0.15. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -2.6%.

The latest indexable market news headline is "Cytek Biosciences to participate at the Singular Research's Las Vegas Invitational Conference" from GlobeNewsWire.

Additional event context on this page matters because analyst consensus is Hold with a median target of $5.13; recent insider activity includes Yan Ming filing G-Gift. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

1.48

P/S

2.38

EV/EBITDA

-20.66

DCF Value

$1.09

FCF Yield

-2.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

51.7%

Operating Margin

-21.5%

Net Margin

-36.2%

ROE

-20.8%

ROA

-16.5%

ROIC

-11.4%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$44.1M$-18.9M$-0.15
Q4 2025$62.1M$-44.1M$-0.34
FY 2025$201.5M$-66.5M$-0.52
Q3 2025$52.3M$-5.5M$-0.04

Analyst Ratings

Consensus

Hold

Target (Consensus)

$5.13

Target (Median)

$5.13

Target Range

$4.75 - $5.50

Strong Buy: 1Buy: 1Hold: 2Sell: 0Strong Sell: 0
Stephens & Co.Overweight
2026-05-13
Morgan StanleyEqual Weight
2026-05-12
TD CowenBuy
2026-01-08
Piper SandlerOverweight
2025-11-11

Trading Activity

Insider Trades

Yan Mingdirector, officer: CHIEF TECHNOLOGY OFFICER
Sell2026-06-16
Holder Michaeldirector
Sell2026-06-12
Holder Michaeldirector
Sell2026-06-12
Holder Michaeldirector
Sell2026-06-12
Holder Michaeldirector
Sell2026-06-12

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.19

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.